vimarsana.com

Page 54 - எங்களுக்கு சர்வதேச வர்த்தகம் தரகு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Market rallies for 4th session

Domestic equity indices extended gains to fourth consecutive trading session on Monday. The Nifty ended near the 14,950 level. All sectoral indices on the NSE ended in the green. As per the provisional closing data, the S&P BSE Sensex, rose 295.94 points or 0.6% to 49,502.50. The Nifty 50 index rallied 119.2 points or 0.8% at 14,942.65. In the broader market, the S&P BSE Mid-Cap index added 0.97% while the S&P BSE Small-Cap index rose 0.94%. The market breadth was strong. On the BSE, 2,079 shares rose and 1027 shares fell. A total of 224 shares were unchanged. Coronavirus Update: Total COVID-19 confirmed cases worldwide stood at 15,83,34,639 with 32,93,120 deaths. India reported 37,45,237 active cases of COVID-19 infection and 2,46,116 deaths while 1,86,71,222 patients have been discharged, according to the data from the Ministry of Health and Family Welfare, Government of India.

Jubilant Pharma receives favourable judgement from US Court of Appeals

In matter related to patent dispute with Bracco DiagnosticsJubilant Pharma, a subsidiary of Jubilant Pharmova, announced that it has received a favorable and unanimous judgment from the United States Court of Appeals summarily affirming Jubilant s earlier favorable rulings from the US Patent Office (PTAB) and the US International Trade Commission (ITC). These two rulings by the Appellate Court deny the appeals filed by Bracco Diagnostics, Inc (Bracco). Jubilant successfully challenged Bracco s patent infringement claims in an Inter Parties Review (IPR) proceeding before the U.S. Patent Office as well as in a separate proceeding in the ITC. In both instances, Jubilant was successful.

Stocks to watch: Avenue Supermarts, Bandhan Bank, Hero Moto, UltraTech

Here are the top stocks to track in today s session: Earnings Today: Twenty-two firms are slated to post their March quarter numbers today such as Chambal Fertilizers & Chemicals, Venky s, JMC Projects and Zydus Wellness Avenue Supermarts: The firm on Saturday reported an increase of 52.56 per cent YoY in its consolidated net profit to Rs 413.87 crore for the fourth quarter ended March 2021. UltraTech Cement: The company reported a 45.2 per cent YoY decline in consolidated net profit to Rs 1,774.13 crore for the fourth quarter ended March 2021 on account of reversal of deferred tax liabilities. Hero MotoCorp: The two-wheeler maker said it has extended the shutdown at its manufacturing facilities across India, global parts centre and R&D facility in Jaipur till May 16. This is the third extension of the shutdown by Hero MotoCorp.

Jubilant Pharmova gains after subsidiary wins over Bracco s legal appeals in US court

Jubilant Pharmova rose 1.70% to Rs 849.70 after the company said its subsidiary, Jubilant Pharma, received a favorable and unanimous judgment from the US Court of Appeals.Jubilant Pharma, a subsidiary of Jubilant Pharmova, announced that it has received a favorable and unanimous judgment from the United States Court of Appeals summarily affirming Jubilant s earlier favorable rulings from the US Patent Office ( PTAB ) and the US International Trade Commission ( ITC ). These two rulings by the Appellate Court deny the appeals filed by Bracco Diagnostics, Inc. Jubilant successfully challenged Bracco s patent infringement claims in an Inter Parties Review (IPR) proceeding before the U.S. Patent Office as well as in a separate proceeding in the ITC. In both instances, Jubilant was successful.

Avenue Supermarts, HDFC, Ultratech Cement in focus

Avenue Supermarts (D-Mart) s consolidated net profit surged 52.7% to Rs 414 crore on 18.4% rise in net sales to Rs 7412 crore in Q4 FY21 over Q4 FY20. Housing Development Finance Corporation (HDFC) on Friday entered into a share purchase agreement for sale of 44,12,000 equity shares of Rs 10 each in HDFC ERGO General Insurance for a cash consideration of Rs 236.48 crore to ERGO International AG. Maruti Suzuki India said that the maintenance shutdown, which was till the 9th May, 2021, is being extended till the 16th May, 2021 keeping in view the current pandemic situation. Ultratech Cement reported 45.2% drop in consolidated net profit to Rs 1775.23 crore in Q4 FY21 as against Rs 3240.23 crore in Q4 FY20. Net sales during the quarter increased 32.7% year-on-year (YoY) to Rs 14405.61 crore. Profit before tax in Q4 FY21 stood at Rs 2638.98 crore, up 80.8% from Rs 1459.43 crore in Q4 FY20. Current tax outgo increased 93.9% to Rs 478.20 crore in Q4 FY21 over Q4 FY20.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.